Feb 20, 2026Elevated Homocysteine Risk: Evidence for Vitamin B12 and TMG StrategiesHomocysteine is a useful risk-context biomarker. B-vitamin repletion and trimethylglycine can lower levels reliably, but clinical-outcome benefit depends on baseline risk and protocol quality.
Feb 12, 2026TMG (Trimethylglycine): Methylation Support, Homocysteine Reduction, and Exercise EvidenceTMG (trimethylglycine/betaine) donates methyl groups to lower homocysteine and supports the methylation cycle alongside B12 and folate. It also shows consistent exercise performance benefits in multiple RCTs — a dual-purpose compound with a clean safety profile.
Jan 24, 2026Homocysteine and Methylation: B12, Folate, TMG — Cardiovascular Risk and ProtocolElevated homocysteine is an independent cardiovascular and cognitive risk factor. The methylation pathway requires adequate B12, folate (as methylfolate in MTHFR variants), and TMG as a methyl donor. Correction is straightforward when deficiency is identified.